Freeline Therapeutics Holdings Plc Stock Price, News & Analysis

FRLN NASDAQ

Company Description

Freeline Therapeutics Holdings Plc (NASDAQ: FRLN) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.

FRLN stock has declined 100.0% over the past year.

This page provides a comprehensive overview of FRLN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

4.4M

Shares outstanding

Freeline Therapeutics Holdings Plc (FRLN) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

April 24, 2024

—

Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

conferences

February 20, 2024

0.00%

Acquisition of Freeline by Syncona Becomes Effective

February 12, 2024

+0.31%

Freeline Shareholders Approve Acquisition by Syncona

acquisition

November 22, 2023

+10.21%

Syncona to Acquire Freeline Therapeutics

acquisition

October 25, 2023

+1.36%

Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual Congress

clinical trial

October 4, 2023

-0.27%

Freeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease

clinical trial

Freeline Therapeutics Holdings Plc has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, acquisition, clinical trial, earnings. View all FRLN news →

SEC Filings

View All

No SEC filings available for FRLN.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

FRLN Company Profile & Sector Positioning

Freeline Therapeutics Holdings Plc (FRLN) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.